News RSS Bioethics News.


Psychedelic compound in ecstasy moves closer to approval to treat PTSD

External Link - Source: Nature

Psychologists have occasionally given people psychedelic drugs such as LSD or magic mushrooms to induce altered states, in an attempt to treat mental illness. Today, many of those drugs are illegal, but if clinical trials testing their efficacy yield positive results, a handful could become prescription medicines in the next decade. The furthest along in this process is MDMA — a drug sold illegally as ecstasy or Molly — which is showing promise in the treatment of post-traumatic stress disorder (PTSD).

This entry was posted in Research Ethics and tagged . Bookmark the permalink.